Key result
Proposed 4-step intervention program outlines depression management for CVD patients during the COVID-19 pandemic.
Why the study?
Depression frequently remains undiagnosed and untreated in patients with cardiovascular disease despite being a risk factor, with mental distress further elevated during the COVID-19 pandemic.
Depression is a critical, underdiagnosed risk factor and comorbidity in CVD patients that requires structured screening and multidisciplinary management, particularly during the COVID-19 pandemic.
Answers are grounded in this paper and cite their sources.
Supports integrated depression screening in CVD care during pandemics; extends observational links but remains hypothesis-generating pending RCTs.
An attempt to review links of cardiovascular disease (CVD) and depression and present appropriate treatment methods for handling depression in the COVID-19 pandemic is made. Although depression constitutes one of the major mental health challenges that humankind must encounter in the 21st century it remains undiagnosed and untreated in CVD patients. Its great influence on the progress of CVD led to its classification as a risk factor along with dyslipidemia, arterial hypertension, diabetes, obesity, substance use, sedentary lifestyle (poor diet, stress) making imperative the need for treatment methods. As during COVID-19 pandemic we witnessed the elevation of mental distress as involving both lifestyle choices and dealing with unprecedented life situations while inducing psychological distress or exacerbating preexisting physical and mental health problems – depression could act both as a contributor to and as the result of CVD. A 4-step intervention program is suggested.
No takes yet. Share an insight, caveat, or question.
Flouda et al. (2023) conducted a review in Depression and Cardiovascular Disease. 4-step intervention program (assessment, triage, planning, contingency management) was evaluated. A 4-step intervention program including assessment, triage, planning, and contingency management is proposed to manage depression in patients with cardiovascular disease during the COVID-19 pandemic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: